搜索临床试验以:COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist
总计96045个结果
-
Pfizer完全的
-
Pfizer完全的
-
Maastricht University Medical CenterAstraZeneca; Cystic Fibrosis Foundation完全的
-
AbbottOrion Corporation, Orion Pharma完全的
-
Erasmus Medical Center完全的
-
GlaxoSmithKline完全的乙型肝炎 | 百日咳 | 破伤风 | 白喉 | 乙肝疾病 | 脑膜炎奈瑟菌血清群 A 和 C 疾病菲律宾
-
Advancis Pharmaceutical Corporation完全的
-
King George's Medical UniversityIndian Council of Medical Research; United States Agency for International Development (USAID)完全的孩子们 | Non-Severe Pneumonia | 五岁以下印度
-
Assaf-Harofeh Medical Center未知
-
King George's Medical UniversityUnited States Agency for International Development (USAID)完全的
-
Amsterdam UMC, location VUmcGlaxoSmithKline; The Netherlands Cancer Institute完全的
-
Hopital LariboisièreMinistry of Health, France完全的
-
Medical University of GrazFresenius Medical Care North America完全的
-
The Cleveland Clinic完全的
-
University of SienaMerck Sharp & Dohme LLC未知
-
UMC UtrechtDutch Health Care Insurance Board完全的
-
Pontificia Universidad Catolica de Chile未知
-
Sunnybrook Health Sciences CentreOntario Ministry of Health and Long Term Care; Sault Area Hospital; Scarborough General Hospital; Michael Garron Hospital 和其他合作者完全的
-
Baxter Healthcare Corporation完全的
-
National Institute on Aging (NIA)Paul B. Beeson Career Development Awards in Aging Research Program完全的
-
Spanish National Health SystemCarlos III Health Institute; Rovi Pharmaceuticals Laboratories终止糖尿病血管病 | 足部溃疡,糖尿病